
Aging doesn’t affect everyone equally, and a new study sheds light on why. Researchers have created a map of human immune aging, revealing that the ratio of two specific immune cell types can predict whether someone will stay healthy or face future disease risks.
The study, published in Immunity, analyzed 12.4 million immune cells from 2,609 adults aged 20 to 90-plus across eight global cohorts. It found that younger people typically have more naive immune cells, while older adults show greater diversity, with some having more inflammation-related cells.
Mapping immune aging with granzyme ratios
The researchers focused on the ratio between granzyme B and granzyme K producing cells, both involved in immune responses. They used data from the UK Biobank, tracking 500,000 participants over 15 years, to explore the link between these cell types and health outcomes.
By applying a computer model to 50,000 baseline blood samples, the team found that individuals with more granzyme B cells at baseline had a higher risk of death and chronic conditions like type 2 diabetes and hypertension a decade later.
This discovery shows how immune systems age differently, even among people of the same age. A shift toward granzyme K cells indicates healthy aging, while granzyme B dominance signals potential issues.
From complex research to simple blood tests
Currently, mapping immune aging requires specialized technology, but the researchers aim to develop a simple, affordable blood test. Maxim N. Artyomov, co-corresponding author, compares this to checking a car’s oil level before issues arise.
Immune Aging Trajectories and Health Risks
Analysis of UK Biobank data showed that granzyme B dominance was linked to a higher likelihood of developing conditions like type 2 diabetes, hypertension, liver disease, and renal failure.
Co-author Marina Terekhova explains, “A higher level of granzyme B cells in a healthy state means the immune system might be already reacting to something.”
Towards Routine Immune Health Monitoring
The DOI for the study is 10.1016/j.immuni.2026.09.012, and it is available on the Immunity website: www.cell.com/immunity/fulltext … 1074-7613(26)00387-0.
Researchers utilized a smaller dataset with CD8 T cell counts and blood protein information to create a model. This model mapped protein traces associated with either granzyme type, providing insights into their dominance and potential immune responses.